Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

Researchers Put Brakes on Study of Tekmira Ebola Drug in West Africa

wsj.com — Tekmira Pharmaceuticals Corp.'s development of a treatment for the Ebola virus has suffered a setback, as researchers have halted enrollment in a clinical trial in Sierra Leone, after finding the drug wasn't helping infected patients. Peter Horby, a professor with the University of Oxford, who led the study, said in an emailed message: "The drug has not demonstrated an overall therapeutic benefit.

How Much Should Cancer Drugs Cost?

Prisoners Sue Massachusetts for Withholding Hepatitis C Drugs

blogs.wsj.com — In the latest example of how the high price tags for hepatitis C drugs are limiting use in some of the most infected populations, two inmates in Massachusetts state prisons have filed a lawsuit accusing the state prison system of failing to provide the drugs to most infected prisoners.

How Much of a Drug Is Safe for Preemies?

wsj.com — Some of the most serious illnesses in small children are routinely treated with drugs that have never been tested in that young population. Now, a group of pediatricians is working to answer such basic questions as how much of a drug is safe to give to an infant.

U.S. Drug Shortages Frustrate Doctors, Patients

finance.yahoo.com — Robin Miller, a 62-year-old oncologist in Atlanta with bladder cancer, was scheduled to receive a potentially lifesaving drug in December. The disruption was due to a global shortage of the drug, BCG, which arose after manufacturing problems at two of the few global suppliers.

U.S. Drug Shortages Frustrate Doctors, Patients

wsj.com — Robin Miller, a 62-year-old oncologist in Atlanta with bladder cancer, was scheduled to receive a potentially lifesaving drug in December. But her doctor's office called shortly before the appointment to say: "Sorry, we don't have any. We can't give it to you," according to Dr. Miller.

Pairing of Two Bristol-Myers Drugs Sees Success in Battling Skin Cancer, Study Says

wsj.com — CHICAGO-A combination of two Bristol-Myers Squibb Co. immune-boosting drugs delayed the progression of the deadly skin cancer melanoma longer than either drug alone, a new study found, though a subgroup of patients might be better off taking just one of the drugs.

Bristol’s Shares Take Hit From Cancer-Drug Results

wsj.com — CHICAGO-A new crop of cancer immunotherapy drugs is showing promise in a widening range of tumor types, while researchers home in on ways to predict which patients are likely to benefit most from the drugs. Studies released Friday at the annual meeting of the American Society of Clinical Oncology showed drugs from Bristol-Myers Squibb Co.

New Push Ties Cost of Drugs to How Well They Work

wsj.com — Express Scripts Holding Co., a large manager of prescription-drug benefits for U.S. employers and insurers, is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.

Actavis Has Discussed Settling Federal Probe of Warner Chilcott Sales Tactics

wsj.com — Drug maker Actavis PLC has held discussions with the Justice Department about resolving an investigation into the marketing tactics at a division, including allegations of improper payments to doctors, according to a regulatory filing and court documents.
More Articles →
Jun 29, 2015

RT @samadacus: @Loftus You ‘overpay’ for a reason. It’s a way to express confidence in the deal/tech, and it’s a way to strengthen your target’s abilities.

Jun 29, 2015

Do you think Celgene is overpaying for access to Juno's CAR-T, or is this a good deal? $CELG $JUNO

Jun 29, 2015

RT @JeanneWhalen: Simplified diagnostic tools that run on solar power are helping bring DNA diagnosis to the field. on.wsj.com/1IFf6ya via @WSJ

Jun 29, 2015

RT @JeanneWhalen: Scoop: DOJ prepares for strict scrutiny of any health-insurer mergers, amid concerns they could limit competition. on.wsj.com/1Kj51LA

Jun 29, 2015

RT @stefaniei: Why Gene-Editing Technology Has Scientists Excited on.wsj.com/1KjqqnV via @Jonathanrockoff

Jun 28, 2015

Yes I lived through the '80s but please tell me Starship didn't have more No. 1's than Peter Gabriel #AwesomeXPN on Philly's @wxpnfm

Jun 19, 2015

RT @JeanneWhalen: 5 things to know about heroin & painkiller addiction in rural America. on.wsj.com/1Il8qoL via @WSJ

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.

Share This Profile